Cancer Center of Irvine
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2011-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.crcl.fr/
Defining Recurrent Disease With Axuminâ„¢
- Conditions
- Prostate AdenocarcinomaProstate Cancer
- Interventions
- Radiation: Salvage Radiation, Axumin
- First Posted Date
- 2019-06-25
- Last Posted Date
- 2019-06-25
- Lead Sponsor
- Cancer Center of Irvine
- Target Recruit Count
- 20
- Registration Number
- NCT03996993
- Locations
- 🇺🇸
Kenneth Tokita, Irvine, California, United States
Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- Interventions
- Device: Cross-linked hyaluronan gel
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Cancer Center of Irvine
- Target Recruit Count
- 10
- Registration Number
- NCT00882232
- Locations
- 🇺🇸
Cancer Center of Irvine, Irvine, California, United States
Use of the Conturaâ„¢ Catheter to Deliver Accelerated Partial Breast Irradiation to "Low-risk" Breast Cancer Patients
Phase 4
Completed
- Conditions
- Breast Cancer
- Interventions
- Device: Accelerated partial breast irradiation
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2018-01-25
- Lead Sponsor
- Cancer Center of Irvine
- Target Recruit Count
- 30
- Registration Number
- NCT00882596
- Locations
- 🇺🇸
Cancer Center of Irvine, Irvine, California, United States
Use of the Conturaâ„¢ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients
Phase 4
Completed
- Conditions
- Breast Cancer
- Interventions
- Device: Contura catheter
- First Posted Date
- 2009-04-16
- Last Posted Date
- 2018-01-25
- Lead Sponsor
- Cancer Center of Irvine
- Target Recruit Count
- 13
- Registration Number
- NCT00882089
- Locations
- 🇺🇸
Cancer Center of Irvine, Irvine, California, United States
© Copyright 2025. All Rights Reserved by MedPath